Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans.
about
Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers.Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteersInfluence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil.Recent bioanalytical methods for quantification of third-generation cephalosporins using HPLC and LC-MS(/MS) and their applications in pharmacokinetic studies.Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency.Future directions in antimicrobial chemotherapy.Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteersPharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children.Different doses of cefetamet pivoxil (Ro 15-8075) in the treatment of acute uncomplicated gonococcal urethritis in menEffect of food on absorption of cefpodoxime proxetil oral suspension in adults.Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects.Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosis.Bioavailability of syrup and tablet formulations of cefetamet pivoxil.Using Monte Carlo simulation to determine optimal dosing regimen for cefetamet sodium for injection.In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil.
P2860
Q33742875-ED3000B1-B764-4923-BCC4-81A054050D6AQ35269538-F5BDCAF6-25A9-4020-8CC3-151487BCC6FAQ35272898-D1AE47D4-EB5A-42CF-8821-C4DA96072DE9Q35311343-029367F4-A75F-4E37-8ADE-D8DC0F2D3981Q35360233-FAA420C9-90BC-465F-94C4-B389B52E99A7Q35530705-CDFEE775-833C-43C6-8E1E-B3478BEBD500Q35843432-7B74602F-5237-405A-8464-EE9C07DD4A17Q36753385-DC3664F5-025D-482E-B4F4-A573DD7000FBQ37896806-83146579-4D2A-4C52-A34F-E905C80869C2Q39779025-5D72E2FF-0479-4299-93BD-89A10D830DE4Q39815033-E3F4360B-2C59-4266-A272-FAF98B5590BCQ39832728-451D41AB-3E00-4A1D-9115-6B8261329748Q39883778-2F3EC786-1569-4F49-B4FE-DA6C33139182Q41727504-A23B0EDC-BC43-4145-AEED-7380419C26B9Q54353071-4C7909B5-5FBF-422A-85FE-85299BA92EC6
P2860
Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans.
description
1988 nî lūn-bûn
@nan
1988 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Pharmacokinetics of cefetamet ...... nous and oral doses in humans.
@ast
Pharmacokinetics of cefetamet ...... nous and oral doses in humans.
@en
type
label
Pharmacokinetics of cefetamet ...... nous and oral doses in humans.
@ast
Pharmacokinetics of cefetamet ...... nous and oral doses in humans.
@en
prefLabel
Pharmacokinetics of cefetamet ...... nous and oral doses in humans.
@ast
Pharmacokinetics of cefetamet ...... nous and oral doses in humans.
@en
P2093
P2860
P356
P1476
Pharmacokinetics of cefetamet ...... nous and oral doses in humans.
@en
P2093
P2860
P304
P356
10.1128/AAC.32.4.573
P407
P577
1988-04-01T00:00:00Z